Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
176 studies found for:    breast,cancer,prevention | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Dexamethasone based mouth
22 Unknown  Statins and Breast Cancer Biomarkers
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
23 Recruiting Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Dietary Supplement: curcumin;   Other: Biomarker analysis;   Other: Assessment of Dietary Intake;   Other: Daily Log
24 Recruiting Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Conditions: Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Drug: Simvastatin;   Drug: Doxorubicin/cyclophosphamide
25 Recruiting Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
Condition: Breast Cancer
Interventions: Drug: Carvedilol;   Other: placebo
26 Recruiting Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
Conditions: Breast Cancer;   Sarcopenia
Interventions: Other: Structured Exercise;   Other: Usual Care
27 Recruiting My Lifestyle Intervention of Food and Exercise
Condition: Breast Cancer
Interventions: Behavioral: Tailored Lifestyle Intervention (TLI);   Behavioral: Commercial Weight Loss Program (CWLP)
28 Recruiting Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Prophylactic radiation to the contralateral breast
29 Unknown  Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: PASIREOTIDE;   Drug: PLACEBO
30 Recruiting Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Condition: Breast Cancer
Intervention: Behavioral: survey web-based or telephone interview
31 Recruiting Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Conditions: Lymphedema;   Breast Cancer
Intervention: Device: Flexitouch
32 Recruiting Incidence of Febrile Neutropenia
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
33 Unknown  Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Conditions: Localized Breast Cancer;   Localized Prostate Cancer;   Patients Receiving External Beam Radiotherapy
Interventions: Dietary Supplement: Organic Germanium;   Dietary Supplement: Placebo
34 Unknown  Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Conditions: Breast Cancer;   Lymphedema;   Perioperative/Postoperative Complications
Interventions: Behavioral: exercise intervention;   Other: educational intervention;   Procedure: assessment of therapy complications;   Procedure: complementary or alternative medicine procedure;   Procedure: management of therapy complications;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
35 Recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Carboplatin;   Biological: Trastuzumab;   Biological: Pertuzumab;   Drug: Goserelin Acetate;   Procedure: Therapeutic Conventional Surgery;   Radiation: Whole Breast Irradiation;   Other: Laboratory Biomarker Analysis;   Drug: Aromatase Inhibition Therapy;   Other: Quality-of-Life Assessment
36 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
37 Recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:
38 Recruiting Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy
Conditions: Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: educational intervention;   Other: counseling intervention;   Behavioral: telephone-based intervention;   Other: questionnaire administration;   Procedure: quality-of-life assessment
39 Recruiting Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Conditions: Breast Cancer;   Lobular Carcinoma;   Invasive Breast Cancer
Intervention: Other: Tissue specimen
40 Recruiting Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Condition: Breast Cancer
Interventions: Drug: Celecoxib;   Drug: Placebo;   Drug: Cholecalciferol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years